# 바이오스페이스 일일 뉴스 리포트 - 2025년 11월 01일


## 주요 헤드라인

1. **Novo’s CEO Doesn’t Seem To Mind Being Big Pharma’s Villian (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/editorial-novos-ceo-doesnt-seem-to-mind-being-big-pharmas-villian>

2. **Novo’s CEO Doesn’t Seem To Mind Being Big Pharma’s Villian (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/editorial-novos-ceo-doesnt-seem-to-mind-being-big-pharmas-villian>

3. **AbbVie’s Immunology Dyad Dominates Again in Q3 (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/abbvies-immunology-dyad-dominates-again-in-q3>

4. **AbbVie’s Immunology Dyad Dominates Again in Q3 (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/abbvies-immunology-dyad-dominates-again-in-q3>

5. **4DMT Sends Eye Disease Asset’s Asia Rights to Otsuka for $85M Upfront (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/4dmt-sends-eye-disease-assets-asia-rights-to-otsuka-for-85m-upfront>

6. **4DMT Sends Eye Disease Asset’s Asia Rights to Otsuka for $85M Upfront (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/4dmt-sends-eye-disease-assets-asia-rights-to-otsuka-for-85m-upfront>

7. **Lilly Refines Pain Pipeline Again, Scrapping Mid-Stage Program (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/lilly-refines-pain-pipeline-again-scrapping-mid-stage-program>


---
*2025년 11월 01일 바이오스페이스 뉴스 피드에서 생성된 리포트*